Sarcoidosis during interferon alpha therapy;Sarkoidose bei interferon-alpha-therapie

Hautarzt

Volumn 48, Issue 7, 1997, Pages 482-487

  Otte, Heinz Günter ^a   Hartig, Christine ^a   Stadler, Rudolf ^a  

^a KLINIKUM MINDEN   (Germany)

Author keywords

Drug side effect; Interferon alpha; Sarcoidosis

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CASE REPORT; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; PUVA; SARCOIDOSIS; SKIN BIOPSY; T CELL LYMPHOMA;

AGED; FEMALE; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; SARCOIDOSIS; SKIN; SKIN DISEASES; SKIN NEOPLASMS;

EID: 0030740139     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050614     Document Type: Article

References (23)

1. Abdi EA, Nguyen GK, Ludwig RN, Dickout WJ (1987) Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer 59:896-900
2. Baselga E, Pujol RM, Barnadas MA, Bordes R et al. (1994) Granulomatous cutaneous T-cell lymphoma. An unusual case with granulomatous lymph node involvement. Eur J Dermatol 4:379-383
3. Biron CA (1994) Cytokines in the generation of immune response to, and resolution of, virus infection. Curr Opin Immunol 6:530-538
4. Blum L, Serfaty L, Wattiaux MJ, Picard O et al. (1993) Sarcoid hypodermic nodules during chronic hepatitis C treated with interferon alpha 2b. Rev Med Interne 14:1161
5. Brinkmann V, Geiger T, Alkan S, Heusser CH (1993) Interferon alfa increases the frequency of interferon gamma-producing human CD4+T cells. J Exp Med 178:1655-1663
6. Christian B, Derriennic X, Guilhot F (1992) Sarcoidosis In association with chronic myeloid leukemia treated with alpha-2b-interferon. Rev Med Interne 13:S462
7. Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM (1995) The role of interleukin-12 in acquired immunity to Myobacterium tuberculosis infection. Immunology 84:423-432
8. Costabel U (1995) Sarkoidose. In:Paumgartner G, Riecker G (Hrsg) Therapie innerer Krankheiten, 8. Aufl. Springer, Berlin Heidelberg New York, S 319-323
9. Crystal RG (1991) Sarcoidosis. In:Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG et al (eds) Principles of internal medicine, 12th ed, pp 1463-1469
10. Fireman EM, Topilsky MR(1994) Sarcoidosis: an organized pattern of reaction from immunology to therapy, Immunol Today 5:199-201
11. Galanaud P (1994) The in vivo expression of cytokine genes in humans. J Lipid Mediat Cell Signal 9:37-41
12. Garlepp MJ, Rose AH, Dench JE, Robinson BW (1994) Clonal analysis of lung and blood T cells in patients with sarcoidosis. Thorax 49:577-585
13. Harada H, Shijubo N, Katoh S, Satoh M, Abe S (1994) Malignant T cell lymphoma associated with sarcoidosis. Sarcoidosis 11:132-134
14. Lever WF, Schaumburg-Lever G (1990) Noninfectious Granulomas. In:Lever WF, Schaumburg-Lever G (eds) Histopathology of the skin, 7th ed. Lippincott, Philadelphia, pp 252-268
15. Liozon E, Cransac M, Remenieras L, Catry-Thomas I et al.(1993) Sarcoidosis:a new complication due to treatment with alpha-interferon. Rev Med Interne 14:1160
16. Muller-Quernheim J (1995) Immunologische Zellaktivierungen bei Sarkoidose: Immunpathogenetische und klinische Implikationen. Immun Infekt 23:80-85
17. O'Garra A, Murphy K (1994) Role of cytokines in determining T-lymphocyte function. Curr Opin Immunol 6:458-466
18. Orfanos CE,GarbeC (Hrsg) (1995) Therapie der Hautkrankheiten, 1. Aufl. Springer, Berlin Heidelberg New York, S 633-636
19. Poynard T, Bedossa P, Chevallier M, Mathurin P et al. (1995) A comparison of three interferon alfa-2b regimens for the long-term-treatment of chronic non-A, non B hepatitis, Multicenter Study Group. N Engl J Med 332:1457-1462
20. Romagnani S (1994) Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 6:838-846
21. Savin JA (1992) Sarcoidosis. In:Champion RH, Burton JL, Ebling FJG (eds) Textbook of dermatology, 5th ed. Blackwell, London Edinburgh Boston, pp 2383-2406
22. Stadler R, Ruszczak Z (1993) Interferon-new additions and indications for use. Dermatol Clin 11:187-199
23. Vial I, Descotes J (1994) Clinical toxicity of the interferons. Drug Saf 10:115-150